NCT00648843View on ClinicalTrials.gov

Food Study of Oxybutynin Chloride Extended-release Tablets 5 mg and Ditropan XL® Tablets 5 mg

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

December 31, 2002

Primary Completion Date

December 31, 2002

Study Completion Date

January 31, 2003

Conditions
Healthy
Interventions
DRUG

Oxybutynin Chloride Extended-release Tablets 5 mg

4x5mg, single dose fed

DRUG

Ditropan XL® Tablets 5 mg

4x5mg, single dose fed

Trial Locations (1)

58104

PRACS Institute, Ltd., Fargo

Sponsors
All Listed Sponsors
lead

Mylan Pharmaceuticals Inc

INDUSTRY